These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 4743883

  • 41. Levodopa and related drugs.
    Med Lett Drugs Ther; 1973 Mar 02; 15(5):21-3. PubMed ID: 4697470
    [No Abstract] [Full Text] [Related]

  • 42. Levodopa in parkinson's disease--Australian collaborative trial.
    Selby G.
    Med J Aust; 1973 Mar 24; 1(12):577-85. PubMed ID: 4700544
    [No Abstract] [Full Text] [Related]

  • 43. Psychosis and other psychiatric manifestations of levodopa therapy.
    Celesia GG, Barr AN.
    Arch Neurol; 1970 Sep 24; 23(3):193-200. PubMed ID: 5456717
    [No Abstract] [Full Text] [Related]

  • 44. [Side effects occurring in the course of treatment of parkinsonism with L-dopa].
    Kuran W.
    Neurol Neurochir Pol; 1973 Sep 24; 7(4):587-94. PubMed ID: 4583001
    [No Abstract] [Full Text] [Related]

  • 45. A unique retinal epitheliopathy is associated with amyotrophic lateral sclerosis/Parkinsonism-Dementia complex of Guam.
    Steele JC, Wresch R, Hanlon SD, Keystone J, Ben-Shlomo Y.
    Mov Disord; 2015 Aug 24; 30(9):1271-5. PubMed ID: 26153661
    [Abstract] [Full Text] [Related]

  • 46. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E, D'Andrea F, Signorelli CD.
    Sist Nerv; 1970 Aug 24; 22(2):99-108. PubMed ID: 5504563
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism.
    Mones RJ, Elizan TS, Siegel GJ.
    J Neurol Neurosurg Psychiatry; 1971 Dec 24; 34(6):668-73. PubMed ID: 5158780
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F, Baroni A, Roveyaz L.
    Sist Nerv; 1970 Dec 24; 22(2):74-81. PubMed ID: 5504560
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).
    McDowell F, Lee JE, Swift T, Sweet RD, Ogsbury JS, Kessler JT.
    Ann Intern Med; 1970 Jan 24; 72(1):29-35. PubMed ID: 5410397
    [No Abstract] [Full Text] [Related]

  • 58. [Clinical study of L-dopa in Parkinson's disease].
    Franken L, Noel G, Lhoas JP, Meyers C, Noel P, Ectors M.
    Brux Med; 1972 Dec 24; 52(12):851-60. PubMed ID: 4575350
    [No Abstract] [Full Text] [Related]

  • 59. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University).
    Gutmann L, Martin JD, Gutrecht JA.
    W V Med J; 1970 Apr 24; 66(4):109-11. PubMed ID: 5264660
    [No Abstract] [Full Text] [Related]

  • 60. Adverse reactions during treatment of Parkinson's disease with levodopa.
    Martin WE.
    JAMA; 1971 Jun 21; 216(12):1979-83. PubMed ID: 5314258
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.